Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by nemo3on Dec 22, 2019 2:11pm

127 Views

Post# 30481682

RE:RE:WHEN IS THE LAST TIME, IF EVER, SOMEONE HAS CONTACTED '60

I agree Impalaman. Too early yet in this story to get mainstream interest. The number of patients treated is still far too small to show whether the same efficacy and safety will prevail in a larger number of patients. And who knows when they will chose to release results - after 5 treated....10...15 ??? Hopefully this time next year, TLT will be bringing cures to many and wealth as well.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity